Page 82 - Read Online

21. Morita M, Kumashiro R, Kubo N, Nakashima Y, Yoshida R, amplifi cation during esophageal carcinogenesis. PLoS Genet
Yoshinaga K, Saeki H, Emi Y, Kakeji Y, Sakaguchi Y, Toh Y, 2011;7:e1001356.
Maehara Y. Alcohol drinking, cigarette smoking, and the 33. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics,
development of squamous cell carcinoma of the esophagus: 2002. CA Cancer J Clin 2005;55:74-108.
epidemiology, clinical fi ndings, and prevention. Int J Clin 34. Jinawath N, Furukawa Y, Hasegawa S, Li M, Tsunoda T,
Oncol 2010;15:126-34. Satoh S, Yamaguchi T, Imamura H, Inoue M, Shiozaki H,
22. Steevens J, Schouten LJ, Goldbohm RA, van den Brandt PA. Nakamura Y. Comparison of gene-expression profi les
Alcohol consumption, cigarette smoking and risk of subtypes between diffuse- and intestinal-type gastric cancers using a
of oesophageal and gastric cancer: a prospective cohort study. genome-wide cDNA microarray. Oncogene 2004;23:6830-44.
Gut 2010;59:39-48. 35. Kim TY, Jong HS, Jung Y, Kang GH, Bang YJ. DNA
23. Tanaka F, Yamamoto K, Suzuki S, Inoue H, Tsurumaru M, hypermethylation in gastric cancer. Aliment Pharmacol Ther
Kajiyama Y, Kato H, Igaki H, Furuta K, Fujita H, Tanaka T, 2004;20 Suppl 1:131-42.
Tanaka Y, Kawashima Y, Natsugoe S, Setoyama T, 36. Nakamura J, Tanaka T, Kitajima Y, Noshiro H, Miyazaki K.
Tokudome S, Mimori K, Haraguchi N, Ishii H, Mori M. Methylation-mediated gene silencing as biomarkers
Strong interaction between the effects of alcohol consumption of gastric cancer: a review. World J Gastroenterol
and smoking on oesophageal squamous cell carcinoma among 2014;20:11991-2006.
individuals with ADH1B and/or ALDH2 risk alleles. Gut 37. Otani K, Li X, Arakawa T, Chan FK, Yu J. Epigenetic-mediated
2010;59:1457-64. tumor suppressor genes as diagnostic or prognostic biomarkers
24. Yokoyama A, Kumagai Y, Yokoyama T, Omori T, Kato H, in gastric cancer. Expert Rev Mol Diagn 2013;13:445-55.
Igaki H, Tsujinaka T, Muto M, Yokoyama M, Watanabe H. 38. Yu QM, Wang XB, Luo J, Wang S, Fang XH, Yu JL, Ling ZQ.
Health risk appraisal models for mass screening for esophageal CDH1 methylation in preoperative peritoneal washes is an
and pharyngeal cancer: an endoscopic follow-up study of
cancer-free Japanese men. Cancer Epidemiol Biomarkers Prev independent prognostic factor for gastric cancer. J Surg Oncol
2012;106:765-71.
2009;18:651-5.
25. Yokoyama A, Omori T, Yokoyama T, Sato Y, Mizukami T, 39. Park TJ, Han SU, Cho YK, Paik WK, Kim YB, Lim IK.
Matsushita S, Higuchi S, Maruyama K, Ishii H, Hibi T. Risk Methylation of O (6)-methylguanine-DNA methyltransferase
gene is associated signifi cantly with K-ras mutation, lymph
of squamous cell carcinoma of the upper aerodigestive tract in node invasion, tumor staging, and disease free survival in
cancer-free alcoholic Japanese men: an endoscopic follow-up
study. Cancer Epidemiol Biomarkers Prev 2006;15:2209-15. patients with gastric carcinoma. Cancer 2001;92:2760-8.
26. Shigaki H, Baba Y, Watanabe M, Iwagami S, Miyake K, 40. Bae SI, Lee HS, Kim SH, Kim WH. Inactivation of
Ishimoto T, Iwatsuki M, Baba H. LINE-1 Hypomethylation in O6-methylguanine-DNA methyltransferase by promoter CpG
noncancerous esophageal mucosae is associated with smoking island hypermethylation in gastric cancers. Br J Cancer
history. Ann Surg Oncol 2012; doi: 10. 1245/s 10434-012-2488-y. 2002;86:1888-92.
27. Iwagami S, Baba Y, Watanabe M, Shigaki H, Miyake K, 41. Yuasa Y, Nagasaki H, Oze I, Akiyama Y, Yoshida S, Shitara K,
Ishimoto T, Iwatsuki M, Sakamaki K, Ohashi Y, Baba H. Ito S, Hosono S, Watanabe M, Ito H, Tanaka H, Kang D,
LINE-1 hypomethylation is associated with a poor prognosis Pan KF, You WC, Matsuo K. Insulin-like growth factor 2
among patients with curatively resected esophageal hypomethylation of blood leukocyte DNA is associated with
squamous cell carcinoma. Ann Surg 2013; doi: 10.1097/ gastric cancer risk. Int J Cancer 2012;131:2596-603.
SLA.0b013e31826d8602. 42. Qu Y, Dang S, Hou P. Gene methylation in gastric cancer.
28. Murata A, Baba Y, Watanabe M, Shigaki H, Miyake K, Clin Chim Acta 2013;424:53-65.
Ishimoto T, Iwatsuki M, Iwagami S, Yoshida N, Oki E, 43. Uemura N, Okamoto S, Yamamoto S, Matsumura N,
Morita M, Nakao M, Baba H. IGF2 DMR0 methylation, loss Yamaguchi S, Yamakido M, Taniyama K, Sasaki N,
of imprinting, and patient prognosis in esophageal squamous Schlemper RJ. Helicobacter pylori infection and the
cell carcinoma. Ann Surg Oncol 2014;21:1166-74. development of gastric cancer. N Engl J Med 2001;345:784-9.
29. Selaru FM, David S, Meltzer SJ, Hamilton JP. Epigenetic 44. Matsusaka K, Kaneda A, Nagae G, Ushiku T, Kikuchi Y,
events in gastrointestinal cancer. Am J Gastroenterol Hino R, Uozaki H, Seto Y, Takada K, Aburatani H,
2009;104:1910-2. Fukayama M. Classifi cation of Epstein-Barr virus-positive
gastric cancers by defi nition of DNA methylation epigenotypes.
30. Agarwal A, Polineni R, Hussein Z, Vigoda I, Bhagat TD,
Bhattacharyya S, Maitra A, Verma A. Role of epigenetic Cancer Res 2011;71:7187-97.
alterations in the pathogenesis of Barrett’s esophagus and 45. Kaneda A, Wakazono K, Tsukamoto T, Watanabe N, Yagi Y,
esophageal adenocarcinoma. Int J Clin Exp Pathol 2012;5:382-96. Tatematsu M, Kaminishi M, Sugimura T, Ushijima T. Lysyl
31. Jin Z, Cheng Y, Gu W, Zheng Y, Sato F, Mori Y, Olaru AV, oxidase is a tumor suppressor gene inactivated by methylation
Paun BC, Yang J, Kan T, Ito T, Hamilton JP, Selaru FM, and loss of heterozygosity in human gastric cancers. Cancer
Agarwal R, David S, Abraham JM, Wolfsen HC, Res 2004;64:6410-5.
Wallace MB, Shaheen NJ, Washington K, Wang J, Canto MI, 46. Ushijima T, Nakajima T, Maekita T. DNA methylation as a
Bhattacharyya A, Nelson MA, Wagner PD, Romero Y, marker for the past and future. J Gastroenterol 2006;41:401-7.
Wang KK, Feng Z, Sampliner RE, Meltzer SJ. A multicenter, 47. Chan AO, Chu KM, Huang C, Lam KF, Leung SY, Sun YW,
double-blinded validation study of methylation biomarkers Ko S, Xia HH, Cho CH, Hui WM, Lam SK, Rashid A.
for progression prediction in Barrett’s esophagus. Cancer Res Association between Helicobacter pylori infection and
2009;69:4112-5. interleukin 1beta polymorphism predispose to CpG island
32. Alvarez H, Opalinska J, Zhou L, Sohal D, Fazzari MJ, methylation in gastric cancer. Gut 2007;56:595-7.
Yu Y, Montagna C, Montgomery EA, Canto M, Dunbar KB, 48. El-Omar EM, Carrington M, Chow WH, McColl KE,
Wang J, Roa JC, Mo Y, Bhagat T, Ramesh KH, Cannizzaro L, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC,
Mollenhauer J, Thompson RF, Suzuki M, Meltzer SJ, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS.
Melnick A, Greally JM, Maitra A, Verma A. Widespread Interleukin-1 polymorphisms associated with increased risk of
hypomethylation occurs early and synergizes with gene gastric cancer. Nature 2000;404:398-402.

Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 3 ¦ October 15, 2015 ¦ 119